FLUNARIZINE IN MIGRAINE PROPHYLAXIS - EFFICACY AND TOLERABILITY OF 5 MG AND 10 MG DOSE LEVELS

被引：20
|
作者：
CENTONZE, V
MAGRONE, D
VINO, M
CAPORALETTI, P
ATTOLINI, E
CAMPANALE, G
ALBANO, O
机构：
[1] Headache Unit, Department of Internal Medicine, University of Bari, Bari
来源：
CEPHALALGIA | 1990年 / 10卷 / 01期
关键词：
Flunarizine; migraine prophylaxis; side effects;
D O I：
10.1046/j.1468-2982.1990.1001017.x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The use of flunarizine, a drug which has proven its efficacy in migraine, is often associated with important side effects. The aim of this paper has been to check their incidence at different dose levels (5 mg vs 10 mg). Our data confirm the occurrence of important side effects (in particular weight gain); on the other hand, they emphasize the dose-dependency of the side effects. © 1990, International Headache Society. All rights reserved.
引用
收藏
页码：17 / 24
页数：8
相关论文
共 50 条
  • [1] EFFICACY AND TOLERABILITY OF FLUNARIZINE IN THE PROPHYLAXIS OF MIGRAINE
    CENTONZE, V
    TESAURO, P
    TRIZIO, T
    MAGRONE, D
    VINO, M
    MACINAGROSSA, G
    CAMPANOZZI, F
    ALTOMARE, E
    ATTOLINI, E
    ALBANO, O
    CEPHALALGIA, 1985, 5 : 163 - 168
  • [2] Prophylactic treatment of migraine with flunarizine: 5 mg or 10 mg?
    Cano, A
    Palomeras, E
    Sanz, P
    Fossas, P
    REVISTA DE NEUROLOGIA, 2001, 33 (01) : 96 - 97
  • [3] Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily
    Diener, HC
    Matias-Guiu, J
    Hartung, E
    Pfaffenrath, V
    Ludin, HP
    Nappi, G
    de Beukelaar, F
    CEPHALALGIA, 2002, 22 (03) : 209 - 221
  • [4] Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily. (vol 22, pg 209, 2002)
    Diener, HC
    Matias-Guiu, J
    Hartung, E
    Pfaffenrath, V
    Ludin, HP
    Nappi, G
    de Beukelaar, F
    CEPHALALGIA, 2002, 22 (06) : 488 - 488
  • [5] Efficacy and tolerability of rizatriptan 10 mg in migraine:: Experience with 70527 patient episodes
    Göbel, H
    Heinze, A
    Heinze-Kuhn, K
    Lindner, V
    HEADACHE, 2001, 41 (03): : 264 - 270
  • [6] EFFICACY AND TOLERABILITY OF METHOTREXATE AT A DOSE OF 15 MG/WEEK AND 10 MG/WEEK IN PATIENTS WITH PULMONARY SARCOIDOSIS
    Gavrysyuk, V. K.
    Merenkova, I. O.
    Gumeniuk, G. L.
    Pendalchuk, N. V.
    Morska, N. D.
    Vlasova, N. A.
    MEDICNI PERSPEKTIVI, 2021, 26 (04): : 56 - 61
  • [7] LOW-DOSE FLUNARIZINE IN THE PROPHYLAXIS OF MIGRAINE
    BASSI, P
    BRUNATI, L
    RAPUZZI, B
    ALBERTI, E
    MANGONI, A
    HEADACHE, 1992, 32 (08): : 390 - 392
  • [8] An audit in to the efficacy and tolerability of flunarizine in the treatment of childhood migraine
    Prabhakar, P.
    Mohammed, B. P.
    Goadsby, P. J.
    JOURNAL OF HEADACHE AND PAIN, 2010, 11 : S75 - S75
  • [9] COMPARISON OF THE EFFICACY AND SAFETY OF FLUNARIZINE TO PROPRANOLOL IN THE PROPHYLAXIS OF MIGRAINE
    GAWEL, MJ
    KREEFT, J
    NELSON, RF
    SIMARD, D
    ARNOTT, WS
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1992, 19 (03) : 340 - 345
  • [10] META-ANALYSIS ON COMPARISON OF EFFICACY AND TOLERABILITY OF ROSUVASTATIN 5 MG/EZETIMIBE 10 MG VERSUS ROSUVASTATIN 20 MG MONOTHERAPY
    Lee, S. -H.
    ATHEROSCLEROSIS, 2022, 355 : E299 - E300
12345